Neuralink did not respond to requests for comment. Employee dissent is not the only headache coming for Musk and his company, however. Now, a federal investigation into potential animal welfare ...
Neuralink is working to address concerns expressed by the US Food and Drug Administration after it rejected an application ...
Elon Musk’s Neuralink, a medical device company, is under federal investigation. Neuralink is being investigated for potential animal-welfare violations amid complaints that its animal testing ...
Screenshot of a YouTube video Neuralink posted last year touting what the company calls humane animal care. The company’s treatment of research animals is under federal investigation ...
By Andrew Paul | Published Mar 3, 2023 3:00 PM EST Try as he might, Elon Musk can’t seem to deliver on Neuralink’s lofty ... However, a new Reuters investigation has revealed the company ...
Neuralink is currently facing probes from the US Department of Agriculture's (USDA) Inspector General at the request of a federal prosecutor and the US Department of Transportation (DOT ...
Elon Musk-owned Neuralink has approached one of the US' biggest neurosurgery centres Barrow Neurological Institute as a potential clinical trials partner as it prepares to test its tech on humans, ...
Authorities charged seven people in Marianna and Forrest City as part of an ongoing federal drug investigation, the Office of the U.S. Attorney, Eastern District of Arkansas, said Tuesday.
SEE ALSO: Elon Musk's Neuralink is reportedly under investigation for animal welfare violations As for why the FDA denied Neuralink's application to begin human trials, sources said there were ...
Neuralink is trying to find an institutional home for human ... according to another Reuters investigation. The FDA denied the company’s first bid for human trial approval last year, according to that ...
The probe was launched amid growing employee ... according to two people who heard the comment. Neuralink could be helped by federal laws passed in recent years aiming to accelerate FDA reviews.
